A comparison of outcomes among hospital survivors with and without severe comorbidity admitted to the intensive care unit

Anaesthesia and Intensive Care
T A WilliamsS Aoun

Abstract

Little is known about the experiences of patients with severe comorbidity discharged from Intensive Care Units (ICUs). This project aimed to determine the effects of an ICU stay for patients with severe comorbidity by comparing 1) quality of life (QOL), 2) the symptom profile of hospital survivors and 3) health service use after hospital discharge for patients admitted to ICU with and without severe comorbidity. A case-control study was used. Patients with severe comorbidity were matched to a contemporaneous cohort of ICU patients by age and severity of illness. Assessment tools were the Medical Outcome Study 36-item short-form and European Organisation for Research and Treatment of Cancer QLQ-C15-PAL questionnaires for QOL and the Symptom Assessment Scale for symptom distress. A proportional odds assumption was performed using an ordinal regression model. The difference in QOL outcome was the dependent variable for each pair. Health service use after discharge from ICU was monitored with patient diaries. Patients aged 18+ years admitted to an ICU in a metropolitan teaching hospital between 2011 and 2012 were included. We recruited 30 cases and 30 controls. QOL improved over the six months after hospital discharge for patients ...Continue Reading

References

Apr 9, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A S StrömgrenP Sjogren
Jul 12, 2002·Journal of the American Geriatrics Society·June R LunneyChristopher Hogan
Oct 19, 2002·Current Opinion in Critical Care·Margaret S Herridge
May 8, 2003·Intensive Care Medicine·Jose HofhuisJan Bakker
Aug 28, 2003·Nursing in Critical Care·Wendy Chaboyer, Joy Grace
Mar 16, 2005·Anaesthesia·B H CuthbertsonL Vale
Sep 16, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Mogens GroenvoldUNKNOWN EORTC Quality of Life Group
Jan 24, 2006·Journal of Clinical Epidemiology·Doug ElliottStephen R Leeder
Mar 4, 2008·The Medical Journal of Australia·Sivagnanavel SenthuranRobert Boots
Apr 25, 2008·Critical Care Medicine·Teresa A WilliamsSteven A R Webb
Jan 24, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Eduardo RochaElizabeth Maccariello
May 7, 2009·Critical Care : the Official Journal of the Critical Care Forum·Richard J ChapmanStephen J Brett
Sep 5, 2009·Journal of the American Society of Nephrology : JASN·Bradford StrijackClaudio Rigatto
Jan 25, 2011·Journal of Palliative Medicine·Samar M AounRuth McConigley

❮ Previous
Next ❯

Citations

Jun 10, 2020·Critical Care : the Official Journal of the Critical Care Forum·Folke SjöbergSören Berg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia
Juliana FranceschiniIlka Lopes Santoro
Intensive Care Medicine
Francisca García LizanaJean-Louis Vincent
© 2022 Meta ULC. All rights reserved